Determinants of oxidative stress and DNA damage (8-OhdG) in squamous cell carcinoma of head and neck

Indian Journal of Cancer

Volumn 49, Issue 3, 2012, Pages 309-315

  Kumar, A ^a   Pant, M C ^b   Singh, H S ^c   Khandelwal, S ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^b KING GEORGE'S MEDICAL UNIVERSITY   (India)

^c CH CHARAN SINGH UNIVERSITY   (India)

Author keywords

8 OHdG; redox status; saliva; squamous cell carcinoma of head and neck

Indexed keywords

GLUTATHIONE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DNA ADDUCT; DNA DAMAGE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HEALTH HAZARD; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; OXIDATIVE STRESS; SALIVA;

ADULT; CARCINOGENESIS; CARCINOMA, SQUAMOUS CELL; DEOXYGUANOSINE; DNA DAMAGE; FEMALE; GLUTATHIONE; HEAD AND NECK NEOPLASMS; HUMANS; INDIA; MALE; MIDDLE AGED; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE NITROGEN SPECIES; SALIVARY DUCTS; TUMOR MARKERS, BIOLOGICAL;

EID: 84871630397     PISSN: 0019509X     EISSN: 19984774     Source Type: Journal    
DOI: 10.4103/0019-509X.104499     Document Type: Article

References (62)

1. Divaris K, Olshan AF, Smith J, Bell ME, Weissler MC, Funkhouser WK, et al. Oral health and risk for head and neck squamous cell carcinoma: The Carolina Head and Neck Cancer Study. Cancer Causes Control 2010; 21:567-75.
2. Yeole BB, Sankaranarayanan R, Sunny M, Sc L, Swaminathan R, Parkin DM. Survival from head and neck cancer in Mumbai (Bombay), India. Cancer 2000; 89:437-44.
3. Trottier H, Burchell AN. Epidemiology of mucosal human papillomavirus infection and associated diseases. Public Health Genomics 2009; 12:291-07.
4. Warnakulasuriya S. Causes of oral cancer-an appraisal of controversies. Br Dent J 2009; 207:471-75.
5. Jeng JH, Chang MC, Hahn LJ. Role of areca nut in betel quidassociated chemical carcinogenesis: current awareness and future perspectives. Oral Oncol 2001; 37:477-92.
6. Patel BP, Rawal UM, Rawal RM, Shukla SN, Patel PS. Tobacco, antioxidant enzymes, oxidative stress, and genetic susceptibility in oral cancer. Am J Clin Oncol 2008; 31:454-59.
7. Ma N, Tagawa T, Hiraku Y, Murata M, Ding X, Kawanishi S. 8-Nitroguanine formation in oral leukoplakia, a premalignant lesion. Nitric Oxide 2006; 14:137-43.
8. Bahar G, Feinmesser R, Shpitzer T, Popovtzer A, Nagler RM. Salivary analysis in oral cancer patients-DNA and protein oxidation, reactive nitrogen species, and antioxidant profile. Cancer 2007; 109:54-9.
9. Patel JB, Shah FD, Shukla SN, Shah PM, Patel PS. Role of nitric oxide and antioxidant enzymes in the pathogenesis of oral cancer. J Cancer Res Ther 2009; 5:247-23.
10. Nair U, Bartsch H, Nair J. Alert for an epidemic of oral cancer due to use of the betel quid substitutes gutkha and pan masala: A review of agents and causative mechanisms. Mutagenesis 2004; 19:251-62.
11. Nair UJ, Floyd RA, Nair J, Bussachini V, Friesen M, Bartsch H. formation of reactive oxygen and 8-hydroxyguanosine in DNA invitro with betel quid ingredients. Chem Biol Interact 1987; 63:157-69.
12. Halliwell B. Oxidative stress and cancer: Have we moved forward? Biochem J 2007; 401:1-11.
13. Afanas'ev I. Signaling by reactive oxygen and nitrogen species in skin diseases. Curr Drug Metab 2010; 11:409-14.
14. Steenken S. Structure, acid/base properties and transformation reactions of purine radicals. Free Radic Res Commun 1989; 6:117-20.
15. Vieira A, Candeias LP, Steenken S. Hydroxyl radical-induced damage to the purine-bases of DNA-invitro studies. Journal De Chimie Physique Et De Physico-Chimie Biologique 1993; 90:881-97.
16. Tenovuo J. The biochemistry of nitrates, nitrites, nitrosamines and other potential carcinogens in human saliva. J Oral Pathol 1986; 15:303-07.
17. Deng DJ. progress of gastric cancer etiology: N-nitrosamides 1999s. World J Gastroenterol 2000; 6:613-18.
18. Ohshima H, Bartsch H. Quantitative estimation of endogenous N-nitrosation in humans by monitoring N-nitrosoproline in urine. Nitric Oxide 3011999:40-9.
19. Ohshima H, Yoshie Y, Auriol S, Gilibert I. Antioxidant and pro-oxidant actions of flavonoids: Effects on DNA damage induced by nitric oxide, peroxynitrite and nitroxyl anion. Free Radic Biol Med 1998; 25:1057-65.
20. Szabó C, Ohshima H. DNA damage induced by peroxynitrite: Subsequent biological effects. Nitric Oxide 1997; 1:373-85.
21. Davis KL, Martin E, Turko IV, Murad F. Novel effects of nitric oxide. Annu Rev Pharmacol Toxicol 2001; 41:203-6.
22. Stich HF, Rosin MP, Bryson L. The inhibitory effect of whole and deproteinized saliva on mutagenicity and clastogenicity resulting from a model nitrosation reaction. Mutat Res 1982; 97:283-92.
23. Nagler RM, Klein I, Zarzhevsky N, Drigues N, Reznick AZ. Characterization of the differentiated antioxidant profile of human saliva. Free Radic Biol Med 2002; 32:268-77.
24. Meister A, Larsson A. Glutathione synthetase deficiency and other disorders of the g-glutamyl cycle. In: Larsson A, editor. The Metabolic Bases of Inhe. 6th ed. ed. New York: McGraw-Hill; 1989. p. 855-68.
25. Pastore A, Piemonte F, Locatelli M, Lo Russo A, Gaeta LM, Tozzi G, et al. Determination of blood total, reduced, and oxidized glutathione in pediatric subjects. Clin Chem 2001; 47:1467-9.
26. Reznick AZ, Hershkovich O, Nagler RM. Saliva-a pivotal player in the pathogenesis of oropharyngeal cancer. Br J Cancer 2004; 91:111-8.
27. Wu HJ, Chi CW, Liu TY. Effects of pH on nicotine-induced DNA damage and oxidative stress. J Toxicol Environ Health A 2005; 68:1511-23.
28. Beevi SS, Rasheed AM, Geetha A. Evaluation of oxidative stress and nitric oxide levels in patients with oral cavity cancer. Jpn J Clin Oncol 2004; 34:379-85.
29. Quiñones L, Lucas D, Godoy J, Cáceres D, Berthou F, Varela N, et al. CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people. Cancer Lett 2001; 174:35-44.
30. Sikdar N, Mahmud SA, Paul RR, Roy B. Polymorphism in CYP1A1 and CYP2E1 genes and susceptibility to leukoplakia in Indian tobacco users. Cancer Lett 2003; 195:33-42.
31. LeBel CP, Ischiropoulos H, Bondy SC. Evaluation of the probe 2′ ,7′-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem Res Toxicol 1992; 5:227-31.
32. Possel H, Noack H, Augustin W, Keilhoff G, Wolf G. 2,7- Dihydrodichlorofluorescein diacetate as a fluorescent marker for peroxynitrite formation. FEBS Lett 1997; 416:175-8.
33. Cathcart R, Schwiers E, Ames BN. Detection of picomole levels of lipid hydroperoxides using a dichlorofluorescein fluorescent assay. Methods Enzymol 1984; 105:352-8.
34. Hensley K, Mou S, Quentin PN. Nitrite determination by colorometric and fluorometric griess diazotiztion assays. Totowa New Jersy: Humana Press; 2003. p. 185-93.
35. Richard WB, Armstrong D. Reduced Glutathione and Glutathione Disulfide. 108. New Jersey: Humana Press; 1998. p. 447-53.
36. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16:1215.
37. Wang LE, Sturgis EM, Eicher SA, Spitz MR, Hong WK, Wei QY. Mutagen sensitivity to benzo(alpha)pyrene diol epoxide and the risk of squamous cell carcinoma of the head and neck. Clin Cancer Res 1998; 4:1773-8.
38. Zhang J, Perry G, Smith MA, Robertson D, Olson SJ, Graham DG, et al. Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons. Am J Pathol 1999; 154:1423-9.
39. Takahama U, Imamura H, Hirota S. Nitration of the salivary component 4-hydroxyphenylacetic acid in the human oral cavity: Enhancement of nitration under acidic conditions. Eur J Oral Sci 2009; 117:555-62.
40. Hayashi I, Morishita Y, Imai K, Nakamura M, Nakachi K, Hayashi T. High-throughput spectrophotometric assay of reactive oxygen species in serum. Mutat Res 2007; 631:55-61.
41. Nagler RM. Saliva as a tool for oral cancer diagnosis and prognosis. Oral Oncol 2009; 45:1006-10.
42. Avivi I, Avraham S, Koren-Michowitz M, Zuckerman T, Aviv A, Ofran Y, et al. Oral integrity and salivary profile in myeloma patients undergoing high-dose therapy followed by autologous SCT. Bone Marrow Transplant 2009; 43:801-6.
43. Ergun S, Troş ala SC, Warnakulasuriya S, Özel S, Önal AE, Ofluolu D, et al. Evaluation of oxidative stress and antioxidant profile in patients with oral lichen planus. J Oral Pathol Med 2011; 40:286-93.
44. Sener DE, Gönenç A, Akinci M, Torun M. Lipid peroxidation and total antioxidant status in patients with breast cancer. Cell Biochem Funct 2007; 25:377-82.
45. Mekary RA, Wu K, Giovannucci E, Fuchs C, Spiegelman D, Willett WC, et al. Total antioxidant capacity intake and colorectal cancer risk in the Health Professionals Follow-up Study. Cancer Causes Control 2010; 21:1315-21.
46. Singh YP, Sachdeva OP, Aggarwal SK, Chugh K, Harbans L. Blood glutathione levels in head and neck malignancies.Indian J Clin Biochem; 2008; 23:290-2.
47. Almadori G, Bussu F, Galli J, Limongelli A, Persichilli S, Zappacosta B, et al. Salivary glutathrone and uric acid levels in patients with head and neck squamous cell carcinoma. Head and Neck 2007; 29:648-54.
48. Suma HR, Prabhu K, Shenoy RP, Annaswamy R, Rao S, Rao A. Estimation of salivary protein thiols and total antioxidant power of saliva in brain tumor patients. J Cancer Res Ther 2010; 6:278-81.
49. Coban T, Mabsout A, Eke BC, Bülbül D, Berberoglu U, Iscan M. Glutathione and lipid peroxidation levels in human breast tumors. Neoplasma 1998; 45:151-6.
50. Peters WH, Wobbes T, Roelofs HM, Jansen JB. Glutathione S-transferases in esophageal cancer. Carcinogenesis 1993; 14: 1377-80.
51. Inci E, Civelek S, Seven A, Inci F, Korkut N, Burçax G. Laryngeal cancer: In relation to oxidative stress. Tohoku J Exp Med 2003; 200:17-23.
52. Gokul S, Patil VS, Jailkhani R, Hallikeri K, Kattappagari KK. Oxidantantioxidant status in blood and tumor tissue of oral squamous cell carcinoma patients. Oral Dis 2010; 16:29-33.
53. Rasheed MH, Beevi SS, Rajaraman R, Bose SJ. Alleviation of oxidative and nitrosative stress following curative resection in patient with oral cavity cancer. J Surg Oncol 2007; 96:194-99.
54. Azad N, Rojanasakul Y, Vallyathan V. Inflammation and lung cancer: Roles of reactive oxygen/nitrogen species. J Toxicol Environ Health B Crit Rev 2008; 11:1-15.
55. Bakan E, Taysi S, Polat MF, Dalga S, Umudum Z, Bakan N, et al. Nitric oxide levels and lipid peroxidation in plasma of patients with gastric cancer. Jpn J Clin Oncol 2002; 32:162-6.
56. Loft S, Danielsen PH, Mikkelsen L, Risom L, Forchhammer L, Moller P. Biomarkers of oxidative damage to DNA and repair. Spain: 3rd Intracellular Proteolysis Meeting, Canary Isl; 2008.
57. Shacter E, Weitzman SA. Chronic inflammation and cancer. Oncology (Williston Park) 2002; 16:217-26.
58. Chisari FV, Ferrari C. Hepatitis B virus immunopathology. Springer Semin Immunopathol 1995; 17:261-81.
59. Liu Z, Wang LE, Strom SS, Spitz MR, Babaian RJ, DiGiovanni J, et al. Overexpression of hMTH in peripheral lymphocytes and risk of prostate cancer: A case-control analysis. Mol Carcinog 2003; 36:123-9.
60. Himmetoglu S, Dincer Y, Ersoy YE, Bayraktar B, Celik V, Akcay T. DNA oxidation and antioxidant status in breast cancer. J Investig Med 2009; 57:720-3.
61. Sato T, Takeda H, Otake S, Yokozawa J, Nishise S, Fujishima S, et al. Increased plasma levels of 8-hydroxydeoxyguanosine are associated with development of colorectal tumors. J Clin Biochem Nutr 2010; 47:59-63.
62. Burger MS, Torino JL, Swaminathan S. DNA damage in human transitional cell carcinoma cells after exposure to the proximate metabolite of the bladder carcinogen 4-aminobiphenyl. Environ Mol Mutagen 2001; 38:1-11.